Skip to main content
TipRanks
Go Ultimate75% OFF

Miricor Enterprises Holdings Ltd (1827) AI Stock Analysis

0 Followers
HK:1827

Miricor Enterprises Holdings Ltd

(HKEX:1827)

Select Model
Rating:66Neutral
Price Target:HKD 0.97â–²(13.68% Upside)
Action:reiterated
Date:09/16/26

The overall score reflects a business that has improved its profitability and balance sheet while still facing pressure from declining revenue and thin margins, making financial performance the key driver of a mid-range rating. Technicals provide a meaningful positive influence, with the price trending above key moving averages and momentum indicators remaining neutral rather than stretched. Valuation contributes moderately, as the stock trades at a middle-range P/E without dividend support, leaving upside dependent on sustaining operational improvements and the current price trend.

Positive Factors
Deleveraging and stronger capital baseMeaningful deleveraging improves financial resilience and reduces the burden that debt can place on future cash flows. A larger equity base also provides greater capacity to absorb operating volatility, support investment, and preserve strategic flexibility over the next several quarters.
Negative Factors
Sharp revenue contractionA sharp revenue decline weakens the foundation for sustainable earnings and makes future performance more dependent on recovery in demand or business activity. Continued top-line pressure could limit operating leverage, reduce reinvestment capacity, and undermine the benefits of recent financial stabilization.

Miricor Enterprises Holdings Ltd (1827) vs. iShares MSCI Hong Kong ETF (EWH)

-30%-20%-10%0%10%20%30%HK:1827+5.69%EWH+8.17%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
HKD 342.00M
Dividend Yield
11.70%
Average Volume (3M)
54.67K
Price to Earnings (P/E)
30.0
Beta (1Y)
-0.21
Revenue Growth
-10.11%
EPS Growth
6.04%
Country
Hong Kong
Employees
235
Sector
Consumer Cyclical
Sector Strength
61
Industry
Medical - Care Facilities

Miricor Enterprises Holdings Ltd Business Overview & Revenue Model

Company Description

Miricor Enterprises Holdings Limited, an investment holding company, provides non-surgical medical aesthetic, wellness beauty services, and skincare products in Hong Kong and Mainland China. It offers non-surgical medical aesthetic services, includin...

Miricor Enterprises Holdings Ltd Financial Statement Overview

Summary

Financial performance is modest: the company has moved from losses to thin profitability, supported by deleveraging and generally solid cash generation, but recent revenue declines and compressed margins keep the score in the low‑to‑mid range.

Income Statement

58Neutral

Balance Sheet

71Positive

Cash Flow

63Positive
Financial statement breakdown
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue363.16M362.39M403.15M494.26M463.12M363.92M
Gross Profit156.92M155.25M211.13M225.37M233.49M194.32M
EBITDA119.69M84.55M106.36M86.62M70.34M94.02M
Net Income10.88M11.23M10.59M-12.62M-20.50M25.38M
Balance Sheet
Total Assets423.67M423.67M471.28M479.44M516.81M476.81M
Cash, Cash Equivalents and Short-Term Investments190.27M258.15M192.17M182.43M116.91M65.68M
Total Debt50.73M50.73M88.76M99.75M130.28M127.58M
Total Liabilities265.40M265.40M323.72M342.68M366.10M305.54M
Stockholders Equity158.27M158.27M147.56M136.76M150.71M171.27M
Cash Flow
Free Cash Flow99.52M68.14M112.07M58.24M72.67M-67.61M
Operating Cash Flow107.59M74.45M114.02M84.45M99.45M44.03M
Investing Cash Flow-53.99M32.42M-30.95M-59.00M-37.84M-97.51M
Financing Cash Flow-57.39M-45.18M-50.03M-55.59M-21.92M-28.73M

Miricor Enterprises Holdings Ltd Technical Analysis

Technical Analysis SentimentNeutral
Last Price0.85

Price Trends

50DMA0.85Positive
100DMA0.79Positive
200DMA0.77Positive

Market Momentum

MACD0.00Positive
RSI46.31Neutral
STOCH7.69Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1827, the sentiment is Neutral. The current price of 0.85 is below the 20-day moving average (MA) of 0.88, above the 50-day MA of 0.85, and above the 200-day MA of 0.77, indicating a neutral trend. The MACD of 0.00 indicates Positive momentum. The RSI at 46.31 is Neutral, neither overbought nor oversold. The STOCH value of 7.69 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1827.

Miricor Enterprises Holdings Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

HK:1827 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:1830HK:183077OutperformHKD 1.98B11.1043.78%9.21%-14.68%-13.60%
HK:1827HK:182766NeutralHKD 342.00M29.967.35%11.70%-10.11%6.04%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
HK:1448HK:144856NeutralHKD 6.03B14.026.50%6.27%――
HK:2521HK:252152NeutralHKD 1.75B48.106.47%―2.78%-41.23%
HK:8483HK:848350NeutralHKD 280.00M-27.70-77.06%―-38.43%-394.12%
HK:0919HK:091948NeutralHKD 67.84M-37.50-0.93%―-2.31%66.07%

* Consumer Cyclical Sector Average

Performance Comparison

0%50%100%150%HK:1827HK:1448HK:0919HK:1830HK:8483HK:2521Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HK:1827 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:1827Miricor Enterprises Holdings Ltd0.850.055.69%
HK:1448Fu Shou Yuan International Group 2.64-0.27-9.31%
HK:0919Modern Healthcare Technology Holdings Limited0.070.002.74%
HK:1830Perfect Medical Health Management Limited1.580.3528.25%
HK:8483Max Sight Group Holdings Limited0.350.21150.00%
HK:2521Shenghui Cleanness Group Holdings Limited0.900.4287.50%

Miricor Enterprises Holdings Ltd Corporate Events

Miricor Refreshes Board, Strengthens Governance With New Independent Director

Sep 21, 2026

Miricor Enterprises Holdings Ltd announced a significant reshuffle of its independent non-executive directors and board committee leadership effective 21 September 2026. Long-serving independent non-executive director Mr. Cheng Yuk Wo has resigned as...

Miricor Enterprises Updates Board and Committee Structure

Sep 21, 2026

Miricor Enterprises Holdings Ltd. has updated its board composition, confirming a mix of executive and independent non-executive directors led by Chairlady and Chief Executive Officer Ms. Lai Ka Yee Gigi. The announcement details the current membersh...

Miricor Shareholders Unanimously Approve AGM Resolutions and Final Dividend

Sep 18, 2026

Miricor Enterprises Holdings Ltd reported that all resolutions tabled at its annual general meeting on 18 September 2026 were approved by shareholders, including the adoption of audited financial statements for the year ended 31 March 2026 and the de...

Miricor Shareholders Unanimously Approve New Option Scheme at EGM

Sep 18, 2026

Miricor Enterprises Holdings Ltd reported that shareholders approved several key resolutions at an extraordinary general meeting held on 18 September 2026, including terminating its existing share option scheme and adopting a new one. The company als...

Miricor Seeks Shareholders’ Approval for New Share Option Scheme and Service Provider Sublimit

Aug 28, 2026

Miricor Enterprises Holdings Ltd has called an extraordinary general meeting for 18 September 2026 in Hong Kong to seek shareholder approval to terminate its existing share option scheme adopted in 2016 and replace it with a new share option scheme....

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 16, 2026